IMPACT THERAPEUTICS
IMPACT Therapeutics is dedicated to the development of similar drugs to treat cancer have independent intellectual property rights and other diseases of the best (best-in-class) of new drugs and its commercialization. The company's senior management team of experienced and professional background complementary and have accumulated more than four decades of experience in drug development and management. General Manager and Chief Scientific Officer Field are an expert in pharmacology and biology.
IMPACT THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2009-06-01
Address:
Nanjing, Jiangsu, China
Country:
China
Website Url:
http://www.impacttherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+02558619059
Total Funding:
90 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content Nginx Euro PHP DigiCert SSL
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Asieris Pharmaceuticals
Asieris Pharmaceuticals is a Chinese biotech company.
CellGenTech
CellGenTech is a Therapeutics Company
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Haizhi Wangju Internet Technology
Haizhi Wangju Internet Technology is a china based company.
Luqa Pharmaceuticals
Luqa Pharmaceuticals is a China-focused company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Tian Tian Express
Tian Tian Express is Hangzhou based company.
Current Employees Featured
Investors List
Exome Asset Management
Exome Asset Management investment in Series D - IMPACT Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series D - IMPACT Therapeutics
CCBT Private Equity
CCBT Private Equity investment in Series D - IMPACT Therapeutics
Bestride
Bestride investment in Series D - IMPACT Therapeutics
Yuexiu Group
Yuexiu Group investment in Series D - IMPACT Therapeutics
Dingxin Capital
Dingxin Capital investment in Series D - IMPACT Therapeutics
China Summit Capital
China Summit Capital investment in Series D - IMPACT Therapeutics
Sam Isaly
Sam Isaly investment in Series D - IMPACT Therapeutics
C&D Emerging Investment
C&D Emerging Investment investment in Series D - IMPACT Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - IMPACT Therapeutics
Official Site Inspections
http://www.impacttherapeutics.com Semrush global rank: 6.99 M Semrush visits lastest month: 656
Unable to get host informations!!!
